These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3092302)

  • 21. [Infusion of high-dosage immunoglobulin G in the therapy of idiopathic thrombocytopenic purpura].
    Ogier C; Sighinolfi L; Serino ML; Ballerini G
    Recenti Prog Med; 1985 Oct; 76(10):523-8. PubMed ID: 4089306
    [No Abstract]   [Full Text] [Related]  

  • 22. A preparation of modified immune serum globulin (human) suitable for intravenous administration. Further characterization and comparison with pepsin-treated intravenous gamma globulin.
    Schroeder DD; Dumas ML
    Am J Med; 1984 Mar; 76(3A):33-9. PubMed ID: 6424455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin preparations.
    Stephan W; Dichtelmüller H
    Lancet; 1983 May; 1(8333):1111. PubMed ID: 6133146
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intravenous immunoglobulin therapy is more and more common. The increasing tempo can force a prioritization of patients, scientists are warning].
    Orn P
    Lakartidningen; 1999 May; 96(18):2186-9. PubMed ID: 10377651
    [No Abstract]   [Full Text] [Related]  

  • 25. [Successful treatment of immune thrombopenia with high-dose intravenous immunoglobulins].
    Schmidt RE; Budde U
    Beitr Infusionther Klin Ernahr; 1983; 11():73-8. PubMed ID: 6686030
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia.
    Gonzalez EB; Guernsey BG; Ingrim NB; Ichikawa Y; Daniels JC
    Arch Intern Med; 1985 May; 145(5):945-6. PubMed ID: 3922322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations].
    Stephan W; Dichtelmüller H
    Arzneimittelforschung; 1983; 33(9):1230-1. PubMed ID: 6416260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose intravenous gammaglobulin therapy of refractory, in particular idiopathic thrombocytopenia in childhood.
    Imbach P; Barandun S; Baumgartner C; Hirt A; Hofer F; Wagner HP
    Helv Paediatr Acta; 1981 Feb; 36(1):81-6. PubMed ID: 6785258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin treatment in multiple sclerosis.
    Achiron A; Cohen IR; Lider O; Melamed E
    Isr J Med Sci; 1995 Jan; 31(1):7-9. PubMed ID: 7836053
    [No Abstract]   [Full Text] [Related]  

  • 30. Placental transfer of intravenous immunoglobulin.
    Hammarström L; Smith CI
    Lancet; 1986 Mar; 1(8482):681. PubMed ID: 2869369
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous immunoglobulin, immunodeficiency syndromes and idiopathic thrombocytopenic purpura. Proceedings of a workshop. Edinburgh, Scotland, 4 and 5 December 1986.
    J Infect; 1987 Jul; 15 Suppl 1():1-65. PubMed ID: 3117895
    [No Abstract]   [Full Text] [Related]  

  • 32. A clinical study of the tolerance and safety of a beta-propiolactone-treated immunoglobulin.
    Mondorf AW; Stephan W; Uthemann H; Schuppan D; Lissner R
    Arzneimittelforschung; 1981; 31(11):1928-30. PubMed ID: 6797445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The pathogenesis of immune complexes and the clinical intravenous use of IgG and enzyme-treated IgG preparation].
    Sedlacek HH; Seiler FR
    Beitr Infusionther Klin Ernahr; 1982; 9():80-94. PubMed ID: 6216882
    [No Abstract]   [Full Text] [Related]  

  • 34. Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia.
    Björkander J; Nikoskelainen J; Leibl H; Lanbeck P; Wallvik J; Lumio JT; Braconier JH; Pavlova BG; Birthistle K; Engl W; Walter S; Ehrlich HJ
    Vox Sang; 2006 May; 90(4):286-93. PubMed ID: 16635071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunoglobulins in the treatment of chronic idiopathic thrombocytopenic purpura].
    Ciepielewska D; Ochocka M
    Pol Tyg Lek; 1988 Feb; 43(7):221-4. PubMed ID: 3136446
    [No Abstract]   [Full Text] [Related]  

  • 36. [Possible applications for immunoglobulin G].
    Krankenpfl J; 2005; 43(1-3):52-3. PubMed ID: 15912842
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravenous immune globulin: a cautionary note.
    Cross AS; Alving BM; Sadoff JC; Baldwin P; Terebelo H; Tang D
    Lancet; 1984 Apr; 1(8382):912. PubMed ID: 6143221
    [No Abstract]   [Full Text] [Related]  

  • 38. On the mutagenicity and immunogenicity of a beta-propiolactone-treated therapeutic IgG-preparation.
    Pincus JH; Mortelmans K; Tanaka W; Stephan W; Lissner R
    Arzneimittelforschung; 1981; 31(11):1924-8. PubMed ID: 6172136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structure and function of immunoglobulins].
    Seiler FR
    Beitr Infusionther Klin Ernahr; 1982; 9():1-15. PubMed ID: 6816212
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative studies of impurities in intravenous immunoglobulin preparations.
    Lundblad JL; Mitra G; Sternberg MM; Schroeder DD
    Rev Infect Dis; 1986; 8 Suppl 4():S382-90. PubMed ID: 3092304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.